We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Integration of High Throughput ‘Omic Platforms into Antibody Discovery

Video   Dec 23, 2016

 

From antibodies to vaccines to T cells, cancer immunotherapy is extending patient lives. Targeted therapies using immune cell receptors can be targeted to either cancer or immune cells. In pursuit of lead structures, ‘omic technologies are revolutionizing the discovery and development of novel biological lead structures. However, ‘omic platforms are first and foremost data generation instruments that require careful integration into workflows. Here, we demonstrate how we have applied next-generation sequencing, big data, biostatistics, and computational immunology to the discovery and development of novel lead structures.

 
 
 
 

Recommended Videos

Harnessing the Power of Immunology to Heal Ourselves

Video

How does our immune system work and how can it be manipulated to to develop new ways of healing our bodies?

WATCH NOW

A "Living Drug" That Could Change the Way We Treat Cancer

Video

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

WATCH NOW

CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer

Video

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE